Institution · Gavi

Most cited papers from Gavi

Gavi

What are the most cited papers from Gavi?

The most cited paper from Gavi is "Global health 2035: a world converging within a generation" (Dean T. Jamison et al., 2013), with 1,238 citations. Next come "Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023" (762) and "Reaching everyone, everywhere with life-saving vaccines" (473).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 59 papers. Every paper with more than 42 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Global health 2035: a world converging within a generation Dean T. Jamison et al. · The Lancet Open access	Dec 2013	1,238
2	Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Simon I Hay et al. · The Lancet Open access2,780 authors	Oct 2025	762
3	Reaching everyone, everywhere with life-saving vaccines Margaret Chan, Chris Elias, Anthony S. Fauci et al. · The Lancet	Feb 2017	473
4	Vaccine development for emerging infectious diseases Jean‐Louis Excler, Melanie K. Saville, Seth Berkley et al. · Nature Medicine Open access	Apr 2021	424
5	Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection Kaja Abbas et al. · The Lancet Global Health Open access	17 Jul 2020	373
6	Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework Karin Stenberg et al. · The Lancet Open access	21 Nov 2013	371
7	Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories Anita Shet, Kelly Carr, M Carolina Danovaro-Holliday et al. · The Lancet Global Health Open access	21 Dec 2021	330
8	Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study Xiang Li et al. · The Lancet Open access	2021	315
9	Community health workers for universal health-care coverage: from fragmentation to synergy Kate Tulenko, Sigrun Møgedal, Muhammad Mahmood Afzal et al. · Bulletin of the World Health Organization Open access	18 Oct 2013	300
10	Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data Subhash Chandir, Danya Arif Siddiqi, Mariam Mehmood et al. · Vaccine Open access	15 Aug 2020	247
11	Meeting the Demand for Results and Accountability: A Call for Action on Health Data from Eight Global Health Agencies Margaret Chan, Michel D. Kazatchkine, Julian Lob‐Levyt et al. · PLoS Medicine Open access	25 Jan 2010	236
12	Inequalities in full immunization coverage: trends in low- and middle-income countries María Clara Restrepo–Méndez, Aluísio J. D. Barros, Kerry LM Wong et al. · Bulletin of the World Health Organization Open access	31 Aug 2016	209
13	The estimated mortality impact of vaccinations forecast to be administered during 2011–2020 in 73 countries supported by the GAVI Alliance Lisa A. Lee, Lauren Franzel, Jessica E. Atwell et al. · Vaccine	Apr 2013	188
14	Accuracy and quality of immunization information systems in forty‐one low income countries Xavier Bosch‐Capblanch, Olivier Ronveaux, Vicki Doyle et al. · Tropical Medicine & International Health Open access	25 Dec 2008	170
15	Impact of COVID-19 lockdown on routine immunisation in Karachi, Pakistan Subhash Chandir, Danya Arif Siddiqi, Hamidreza Setayesh et al. · The Lancet Global Health Open access	29 Jun 2020	162
16	Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020 Sachiko Ozawa et al. · Bulletin of the World Health Organization Open access	27 Jun 2017	154
17	Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine Grace Macklin, Kathleen M. O’Reilly, Nicholas C. Grassly et al. · Science Open access	19 Mar 2020	151
18	Measles Peter M. Strebel, Walter Albert Orenstein · New England Journal of Medicine	10 Jul 2019	136
19	State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household health surveys Ahmad Reza Hosseinpoor, Nicole Bergen, Anne Schlotheuber et al. · The Lancet Global Health Open access	4 Aug 2016	123
20	Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls Jennifer R. Verani et al. · Vaccine Open access	22 Apr 2017	113
21	Missed opportunities in full immunization coverage: findings from low- and lower-middle-income countries María Clara Restrepo–Méndez, Aluísio J. D. Barros, Kerry LM Wong et al. · Global Health Action Open access	3 May 2016	111
22	Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health David Watkins et al. · The Lancet	Oct 2018	107
23	Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world Jaspreet Toor et al. · eLife Open access	12 Jul 2021	102
24	Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward Umesh D. Parashar, Hope L. Johnson, Andrew Duncan Steele et al. · Clinical Infectious Diseases Open access	8 Apr 2016	98
25	Addressing the persistent inequities in immunization coverage Mickey Chopra, Zulfiqar Ahmed Bhutta, Diana Chang Blanc et al. · Bulletin of the World Health Organization Open access	10 Jan 2019	95
26	Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination Sebastian Funk, Jennifer K. Knapp, Emmaculate J. Lebo et al. · BMC Medicine Open access	24 Sep 2019	95
27	Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries Katy A. M. Gaythorpe et al. · eLife Open access	24 Jun 2021	90
28	Cascading contingent protection Bernard M. Hoekman, Michael P. Leidy · European Economic Review	May 1992	90
29	Why Reaching Zero-Dose Children Holds the Key to Achieving the Sustainable Development Goals Dan Hogan, Anuradha Gupta · Vaccines Open access	31 Mar 2023	89
30	Country-level predictors of vaccination coverage and inequalities in Gavi-supported countries Catherine Arsenault, Mira Johri, Arijit Nandi et al. · Vaccine	29 Mar 2017	89
31	Monitoring equity in vaccination coverage: A systematic analysis of demographic and health surveys from 45 Gavi-supported countries Catherine Arsenault, Sam B. Harper, Arijit Nandi et al. · Vaccine	7 Jan 2017	89
32	Estimates of the number and distribution of zero-dose and under-immunised children across remote-rural, urban, and conflict-affected settings in low and middle-income countries A. S. Wigley, Josh Lorin, Dan Hogan et al. · PLOS Global Public Health Open access	26 Oct 2022	88
33	The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries Angela Ya-Ping Chang, Carlos Riumalló‐Herl, Nicole A. Perales et al. · Health Affairs Open access	Feb 2018	88
34	Enhanced Diagnosis of Pneumococcal Meningitis with Use of the Binax NOW Immunochromatographic Test ofStreptococcus pneumoniaeAntigen: A Multisite Study Jennifer C. Moïsi, Samir Kumar Saha, Adegoke G. Falade et al. · Clinical Infectious Diseases Open access	3 Feb 2009	87
35	The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access Jonne Terstappen et al. · The Lancet Infectious Diseases Open access	23 Sep 2024	85
36	Gavi HPV Programs: Application to Implementation Celina M. Hanson, Linda O'Neal Eckert, Paul N. Bloem et al. · Vaccines Open access	20 May 2015	84
37	Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study Hyolim Kang, Megan Auzenbergs, Hannah Clapham et al. · The Lancet Infectious Diseases ReviewOpen access	9 Feb 2024	82
38	AIDS: lessons learnt and myths dispelled Peter K. Piot, Michel D. Kazatchkine, Mark Dybul et al. · The Lancet	20 Mar 2009	82
39	Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys C. Edson Utazi, John Ndegwa Wagai, Oliver Pannell et al. · Vaccine Open access	29 Feb 2020	76
40	Cholera outbreaks in sub-Saharan Africa during 2010-2019: a descriptive analysis Qulu Zheng, Francisco Javier Luquero, Iza Ciglenečki et al. · International Journal of Infectious Diseases Open access	20 May 2022	70
41	Can community health workers increase coverage of reproductive health services? Kavitha Viswanathan, Peter Meredith Hansen, Md Hafizur Rahman et al. · Journal of Epidemiology & Community Health	7 Nov 2011	65
42	Reassessing the value of vaccines Till Bärnighausen et al. · The Lancet Global Health Open access	24 Apr 2014	65
43	COVID-19 needs a big science approach Seth Berkley · Science Open access	25 Mar 2020	64
44	Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects Siobhan Botwright, Taylor A. Holroyd, Shreya Nanda et al. · PLoS ONE Open access	10 Oct 2017	64
45	Using solar-powered refrigeration for vaccine storage where other sources of reliable electricity are inadequate or costly Steve McCarney, Joanie Robertson, Juliette Arnaud et al. · Vaccine Open access	9 Aug 2013	63
46	Inequities in childhood immunisation coverage associated with socioeconomic, geographic, maternal, child, and place of birth characteristics in Kenya Simon G Allan, Ifedayo Adetifa, Kaja Abbas · BMC Infectious Diseases Open access	10 Jun 2021	62
47	Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review Charlotte Wirtz, Yasmin Ahmed Mohamed, Danielle Marie Claire Engel et al. · Vaccine ReviewOpen access	Dec 2021	59
48	Children of more empowered women are less likely to be left without vaccination in low- and middle-income countries: A global analysis of 50 DHS surveys Andrea Tuchtenhagen Wendt, Thiago Melo Santos, Bianca O. Cata-Preta et al. · Journal of Global Health Open access	25 Mar 2022	57
49	Facilitating the development of urgently required combination vaccines William P. Hausdorff, Shabir Ahmed Madhi, Gagandeep Kang et al. · The Lancet Global Health Open access	15 Apr 2024	55
50	Innovations in cold chain equipment for immunization supply chains Joanie Robertson, Lauren Franzel, Denis Maire · Vaccine Open access	30 Mar 2017	55

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.